Familial aggregation of age-related macular degeneration in the Utah population

Vision Research

Volumn 48, Issue 3, 2008, Pages 494-500

  Luo, Ling ^a,b   Harmon, Jennifer ^a   Yang, Xian ^a   Chen, Haoyu ^a   Patel, Shrena ^a   Mineau, Geraldine ^a   Yang, Zhenglin ^a,c   Constantine, Ryan ^a   Buehler, Jeanette ^a   Kaminoh, Yuuki ^a   Ma, Xiang ^a   Wong, Tien Y ^d   Zhang, Maonian ^b   Zhang, Kang ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Age related macular degeneration; Genetic epidemiology; Genetics

Indexed keywords

ARTICLE; CONTROLLED STUDY; FAMILY ASSESSMENT; FAMILY SIZE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; PEDIGREE; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR;

EPIDEMIOLOGIC METHODS; EYE DISEASES, HEREDITARY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MACULAR DEGENERATION; MALE; PEDIGREE; UTAH;

EID: 38749154667     PISSN: 00426989     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.visres.2007.11.013     Document Type: Article

References (46)

1. Bai Y., Sherman S., Khoury M.J., and Flanders W.D. Bias associated with study protocols in epidemiologic studies of disease familial aggregation. American Journal of Epidemiology 151 (2000) 927-937
2. Bean L., Mineau G., and Anderton D. Fertility change on the American frontier: Adaptation and innovation (1990), University of California Press, Berkeley
3. Berthelemy-Okazaki N., Zhao Y., Yang Z., Camp N.J., Farnham J., Parker D., et al. Examination of ELN as a candidate gene in the Utah intracranial aneurysm pedigrees. Stroke 36 (2005) 1283-1284
4. Boucher K.M., and Kerber R.A. Measures of familial aggregation as predictors of breast-cancer risk. Journal of Epidemiology and Biostatistics 6 (2001) 377-385
5. Bruzzi P., Green S.B., Byar D.P., Brinton L.A., and Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. American Journal of Epidemiology 122 (1985) 904-914
6. Cameron D.J., Yang Z., Gibbs D., Chen H., Kaminoh Y., Jorgensen A., et al. HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration. Cell Cycle 6 (2007) 1122-1125
7. Dewan A., Liu M., Hartman S., Zhang S.S., Liu D.T., Zhao C., et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314 (2006) 989-992
8. Edwards A.O., Ritter III R., Abel K.J., Manning A., Panhuysen C., and Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005) 421-424
9. Friedman D.S., O'Colmain B.J., Munoz B., Tomany S.C., McCarty C., de Jong P.T., et al. Prevalence of age-related macular degeneration in the United States. Archives of Ophthalmology 122 (2004) 564-572
10. Goldgar D.E., Easton D.F., Cannon-Albright L.A., and Skolnick M.H. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. Journal of the National Cancer Institute 86 (1994) 1600-1608
11. Grizzard S.W., Arnett D., and Haag S.L. Twin study of age-related macular degeneration. Ophthalmic Epidemiology 10 (2003) 315-322
12. Hageman G.S., Anderson D.H., Johnson L.V., Hancox L.S., Taiber A.J., Hardisty L.I., et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 7227-7232
13. Hageman G.S., Luthert P.J., Victor Chong N.H., Johnson L.V., Anderson D.H., and Mullins R.F. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Progress in Retina and Eye Research 20 (2001) 705-732
14. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005) 419-421
15. Hammond C.J., Webster A.R., Snieder H., Bird A.C., Gilbert C.E., and Spector T.D. Genetic influence on early age-related maculopathy: A twin study. Ophthalmology 109 (2002) 730-736
16. Heiba I.M., Elston R.C., Klein B.E., and Klein R. Sibling correlations and segregation analysis of age-related maculopathy: The Beaver Dam Eye Study. Genetic Epidemiology 11 (1994) 51-67
17. Jorde L.B. Inbreeding in the Utah Mormons: An evaluation of estimates based on pedigrees, isonymy, and migration matrices. Annals of Human Genetics 53 (1989) 339-355
18. Kamb A., Shattuck-Eidens D., Eeles R., Liu Q., Gruis N.A., Ding W., et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genetics 8 (1994) 23-26
19. Kaplan H.J., Leibole M.A., Tezel T., and Ferguson T.A. Fas ligand (CD95 ligand) controls angiogenesis beneath the retina. Nature Medicine 5 (1999) 292-297
20. Kerber R.A. Method for calculating risk associated with family history of a disease. Genetic Epidemiology 12 (1995) 291-301
21. Klaver C.C., Wolfs R.C., Assink J.J., van Duijn C.M., Hofman A., and de Jong P.T. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Archives of Ophthalmology 116 (1998) 1646-1651
22. Klein M.L., Mauldin W.M., and Stoumbos V.D. Heredity and age-related macular degeneration. Observations in monozygotic twins. Archives of Ophthalmology 112 (1994) 932-937
23. Klein R., Klein B.E., and Linton K.L. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99 (1992) 933-943
24. Klein R., Klein B.E., and Moss S.E. Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. American Journal of Epidemiology 147 (1998) 103-110
25. Klein B.E., Klein R., Lee K.E., Moore E.L., and Danforth L. Risk of incident age-related eye diseases in people with an affected sibling: The Beaver Dam Eye Study. American Journal of Epidemiology 154 (2001) 207-211
26. Klein R., Klein B.E., Tomany S.C., and Moss S.E. Ten-year incidence of age-related maculopathy and smoking and drinking: The Beaver Dam Eye Study. American Journal of Epidemiology 156 (2002) 589-598
27. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., et al. Complement factor H polymorphism in age-related macular degeneration. Science (2005)
28. Krzystolik M.G., Afshari M.A., Adamis A.P., Gaudreault J., Gragoudas E.S., Michaud N.A., et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Archives of Ophthalmology 120 (2002) 338-346
29. McLellan T., Jorde L.B., and Skolnick M.H. Genetic distances between the Utah Mormons and related populations. American Journal of Human Genetics 36 (1984) 836-857
30. Meyers S.M. A twin study on age-related macular degeneration. Transactions of the American Ophthalmological Society 92 (1994) 775-843
31. Meyers S.M., Greene T., and Gutman F.A. A twin study of age-related macular degeneration. American Journal of Ophthalmology 120 (1995) 757-766
32. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266 (1994) 66-71
33. Okamoto N., Tobe T., Hackett S.F., Ozaki H., Vinores M.A., LaRochelle W., et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: A new model of intraretinal and subretinal neovascularization. American Journal of Pathology 151 (1997) 281-291
34. Penfold P.L., Killingsworth M.C., and Sarks S.H. Senile macular degeneration: The involvement of immunocompetent cells. Graefe's Archive for Clinical and Experimental Ophthalmology 223 (1985) 69-76
35. Seddon J.M., Ajani U.A., and Mitchell B.D. Familial aggregation of age-related maculopathy. American Journal of Ophthalmology 123 (1997) 199-206
36. Seddon J.M., Cote J., Page W.F., Aggen S.H., and Neale M.C. The US twin study of age-related macular degeneration: Relative roles of genetic and environmental influences. Archives of Ophthalmology 123 (2005) 321-327
37. Skolnick M., Bean L., Dintelman S., and Mineau G. A computerized family history database system. Social Science Research 63 (1979) 506-523
38. Smith W., Assink J., Klein R., Mitchell P., Klaver C.C., Klein B.E., et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 108 (2001) 697-704
39. Tavtigian S.V., Simard J., Rommens J., Couch F., Shattuck-Eidens D., Neuhausen S., et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nature Genetics 12 (1996) 333-337
40. Tavtigian S.V., Simard J., Teng D.H., Abtin V., Baumgard M., Beck A., et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nature Genetics 27 (2001) 172-180
41. van Leeuwen R., Klaver C.C., Vingerling J.R., Hofman A., and de Jong P.T. Epidemiology of age-related maculopathy: A review. European Journal of Epidemiology 18 (2003) 845-854
42. Vingerling J.R., Dielemans I., Hofman A., Grobbee D.E., Hijmering M., Kramer C.F., et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102 (1995) 205-210
43. Wooster R., Neuhausen S.L., Mangion J., Quirk Y., Ford D., Collins N., et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265 (1994) 2088-2090
44. Wylie J.E., and Mineau G.P. Biomedical databases: Protecting privacy and promoting research. Trends in Biotechnology 21 (2003) 113-116
45. Yang Z., Camp N.J., Sun H., Tong Z., Gibbs D., Cameron D.J., et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314 (2006) 992-993
46. Zareparsi S., Branham K.E., Li M., Shah S., Klein R.J., Ott J., et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. American Journal of Human Genetics 77 (2005) 149-153